Sponsor · clinical trials

Medtronic Cardiovascular clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our USA, France, Israel, UK, Germany, Spain, Netherlands, Italy, Switzerland, Canada, Denmark, Sweden, Japan, Australia, China, Ireland, Austria, Portugal, Belgium and Taiwan registers with Medtronic Cardiovascular as lead sponsor. Synced 10 Nov 2026

17Current trials

7Recruiting now

0Drugs in these trials

20Trial registers

Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Synced 10 Nov 2026 · Editorial standards

At a glance

Medtronic Cardiovascular is the lead sponsor of 17 current clinical trials in our USA, France, Israel, UK, Germany, Spain, Netherlands, Italy, Switzerland, Canada, Denmark, Sweden, Japan, Australia, China, Ireland, Austria, Portugal, Belgium and Taiwan registers. 7 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is AAA - Abdominal Aortic Aneurysm.

Company profile on this site (news, sites, medicines, approvals): Medtronic Ireland (IE) →

ClinicalTrials.gov trials by status

Recruiting741%
Active, closed1059%

Trials by phase

Not applicable1588%
Observational212%

Clinical trials sponsored by Medtronic Cardiovascular

17 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation NCT07321899 · Severe Tricuspid Regurgitation	Not applicable	Recruiting	2026-09	USA
Harmony TPV EMEA PMS NCT06906926 · Severe Pulmonary Valve Regurgitation	Not applicable	Recruiting	2025-07	Ireland, Germany, France, Spain, Italy, Sweden, Denmark, Israel
Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial NCT05496998 · Mitral Regurgitation	Not applicable	Recruiting	2023-02	UK, Germany, France, Spain, Italy, Netherlands, Denmark, Switzerland
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. NCT03242642 · Mitral Valve Regurgitation	Not applicable	Recruiting	2017-10	USA, Denmark, Canada, Israel
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial NCT05378347 · Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)	Not applicable	Recruiting	2023-01	UK, USA, China, Germany, France, Spain, Italy, Netherlands, Switzerland, Japan, Taiwan, Israel
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE NCT06777368 · Aortic Stenosis	Observational	Recruiting	2025-02	USA
Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA) NCT07754318 · ClinicalTrials.gov ↗ · AAA - Abdominal Aortic Aneurysm	Not applicable	Recruiting	2026-08	China
Evolut™ EXPAND TAVR II Pivotal Trial NCT05149755 · Moderate Aortic Valve Stenosis	Not applicable	Active, closed	2022-04	Ireland, UK, USA, Germany, France, Spain, Italy, Netherlands, Belgium, Sweden, Switzerland, Austria, Canada, Japan, Australia, Israel
TTVR Early Feasibility Study NCT04433065 · Tricuspid Regurgitation	Not applicable	Active, closed	2020-10	USA
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial NCT04722250 · Symptomatic Aortic Stenosis, Aortic Valve Stenosis, Aortic Valve Replacement	Not applicable	Active, closed	2021-04	UK, USA, Germany, France, Spain, Italy, Netherlands, Denmark, Switzerland, Portugal, Canada, Israel
Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study NCT03635424 · Bicuspid Aortic Valve	Not applicable	Active, closed	2018-10	USA, Israel
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). NCT01586910 · Severe Aortic Stenosis	Not applicable	Active, closed	2012-04	UK, USA, Germany, Spain, Netherlands, Sweden, Denmark, Switzerland, Canada, Israel
Endurant CHevAr New Indication Trial: ENCHANT NCT03320252 · AAA - Abdominal Aortic Aneurysm	Observational	Active, closed	2017-10	UK, Germany, France, Spain, Italy, Netherlands, Sweden, Switzerland, Austria, Portugal
Transcatheter Mitral Valve Replacement System (TMVR) Pilot Study and The Early Feasibility Study of the TMVR Transseptal System NCT02322840 · Mitral Valve Insufficiency	Not applicable	Active, closed	2015-04	UK, USA, France, Denmark, Australia
Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients NCT02701283 · Aortic Valve Stenosis	Not applicable	Active, closed	2016-03	USA, France, Netherlands, Canada, Japan, Australia, Israel
Harmony TPV Post-Approval Study NCT05077774 · ClinicalTrials.gov ↗ · Congenital Heart Disease, Tetrology of Fallot, RVOT Anomaly	Not applicable	Active, closed	2021-10	USA, Canada
Evolut PRO China Clinical Study NCT04982588 · ClinicalTrials.gov ↗ · Severe, Symptomatic Aortic Stenosis	Not applicable	Active, closed	2021-07	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Conditions in Medtronic Cardiovascular trials

22 conditions

AAA - Abdominal Aortic Aneurysm2Aortic Valve Stenosis2Moderate Aortic Valve Stenosis1Severe Pulmonary Valve Regurgitation1Mitral Regurgitation1Abdominal Aortic Aneurysm1Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)1Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)1Symptomatic Aortic Stenosis1Aortic Valve Replacement1Mitral Valve Insufficiency1Severe Aortic Stenosis1Severe Tricuspid Regurgitation1Tricuspid Regurgitation1 Congenital Heart Disease1Tetrology of Fallot1RVOT Anomaly1Pulmonary Regurgitation1Mitral Valve Regurgitation1Aortic Stenosis1Bicuspid Aortic Valve1Severe, Symptomatic Aortic Stenosis1

By trial register

Register	Trials	Recruiting
Clinical trials in USA	12	4
Clinical trials in France	8	3
Clinical trials in Israel	8	3
Clinical trials in UK	7	2
Clinical trials in Germany	7	3
Clinical trials in Spain	7	3
Clinical trials in Netherlands	7	2
Clinical trials in Italy	6	3
Clinical trials in Switzerland	6	2
Clinical trials in Canada	6	1
Clinical trials in Denmark	6	3
Clinical trials in Sweden	4	1
Clinical trials in Japan	3	1
Clinical trials in Australia	3	0
Clinical trials in China	3	2
Clinical trials in Ireland	2	1
Clinical trials in Austria	2	0
Clinical trials in Portugal	2	0
Clinical trials in Belgium	1	0
Clinical trials in Taiwan	1	1

A trial with sites in more than one country appears in each of those registers.

Other sponsors in AAA - Abdominal Aortic Aneurysm

Sponsor	Trials
Endologix	1

Sponsors with the most current trials registered for this condition.

Questions about Medtronic Cardiovascular trials

How many clinical trials does Medtronic Cardiovascular sponsor?

Medtronic Cardiovascular is the lead sponsor of 17 current trials on ClinicalTrials.gov in our USA, France, Israel, UK, Germany, Spain, Netherlands, Italy, Switzerland, Canada, Denmark, Sweden, Japan, Australia, China, Ireland, Austria, Portugal, Belgium and Taiwan registers, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.

Are Medtronic Cardiovascular trials recruiting?

Yes. 7 of its 17 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Does Medtronic Cardiovascular have clinical trials in Ireland?

Yes. 2 trials in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.